Lixisenatide shows benefits comparable to exenatide in diabetes

06/6/2013 | PhysiciansBriefing.com

Once-daily lixisenatide was as effective as twice-daily exenatide in improving A1C and fasting plasma glucose levels in adult type 2 diabetes patients who showed poor response to metformin, according to a study in Diabetes Care. Researchers also noted lower incidence of symptomatic hypoglycemia and gastrointestinal events among lixisenatide-treated patients than in those who took exenatide. However, the lixisenatide group had less weight loss compared with the exenatide group, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR